Passage Bio
Kathleen Borthwick is an experienced finance executive currently serving as Chief Financial Officer at Passage Bio. Previously, Kathleen held various leadership roles at Johnson & Johnson, including Group Finance Lead for Medical Devices and Senior Director for Janssen EMEA Mid-Sized Markets, as well as Senior Director of Manufacturing & Technical Operations Finance for Janssen Supply Group. Kathleen holds a BS in Accounting and Health Care Management from the University of Pennsylvania and an MBA from The Tuck School of Business at Dartmouth.
This person is not in the org chart
This person is not in any offices
Passage Bio
1 followers
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).